- Home
- ALDX vs FTF Comparison
ALDX vs FTF Comparison
Compare ALDX & FTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- FTF
- Stock Information
- Founded
- ALDX 2004
- FTF 2003
- Country
- ALDX United States
- FTF United States
- Employees
- ALDX N/A
- FTF N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- FTF Finance/Investors Services
- Sector
- ALDX Health Care
- FTF Finance
- Exchange
- ALDX Nasdaq
- FTF Nasdaq
- Market Cap
- ALDX 296.0M
- FTF 256.6M
- IPO Year
- ALDX 2014
- FTF N/A
- Fundamental
- Price
- ALDX $4.72
- FTF $6.13
- Analyst Decision
- ALDX Strong Buy
- FTF
- Analyst Count
- ALDX 2
- FTF 0
- Target Price
- ALDX $9.50
- FTF N/A
- AVG Volume (30 Days)
- ALDX 625.1K
- FTF 153.9K
- Earning Date
- ALDX 11-05-2025
- FTF 01-01-0001
- Dividend Yield
- ALDX N/A
- FTF 11.45%
- EPS Growth
- ALDX N/A
- FTF N/A
- EPS
- ALDX N/A
- FTF N/A
- Revenue
- ALDX N/A
- FTF N/A
- Revenue This Year
- ALDX N/A
- FTF N/A
- Revenue Next Year
- ALDX $63.48
- FTF N/A
- P/E Ratio
- ALDX N/A
- FTF N/A
- Revenue Growth
- ALDX N/A
- FTF N/A
- 52 Week Low
- ALDX $1.14
- FTF $5.76
- 52 Week High
- ALDX $7.20
- FTF $6.56
- Technical
- Relative Strength Index (RSI)
- ALDX 34.90
- FTF 35.32
- Support Level
- ALDX $4.85
- FTF $6.11
- Resistance Level
- ALDX $5.27
- FTF $6.23
- Average True Range (ATR)
- ALDX 0.27
- FTF 0.05
- MACD
- ALDX -0.05
- FTF 0.00
- Stochastic Oscillator
- ALDX 14.15
- FTF 40.23
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About FTF Franklin Limited Duration Income Trust of Beneficial Interest
Franklin Limited Duration Income Trust is a closed-end investment company based in the United States. It conducts its investment to provide high, current income, with a secondary objective of capital appreciation. To align with its investment objective is to invest in a diversified mix of fixed-income securities. Its portfolio is dominated by considerable investments in high-yield corporate bonds while touching upon other avenues such as senior secured floating rate corporate loans, mortgage-backed securities, commercial mortgage-backed securities, asset-backed securities, common stocks, and other short-term investments.